ANA 773, with the CAS number 1174920-78-5, is a synthetic compound that belongs to the class of cannabinoids. It is known for its selective agonistic activity at the cannabinoid receptors, particularly the CB1 receptor, which is primarily associated with the psychoactive effects of cannabinoids. The compound has been studied for its potential therapeutic applications, including its effects on appetite stimulation and pain relief. ANA 773 is characterized by its ability to cross the blood-brain barrier, leading to central nervous system effects. Its chemical structure includes a bicyclic framework, which contributes to its receptor binding affinity. As with many synthetic cannabinoids, the pharmacological profile of ANA 773 may vary based on dosage and individual biological factors. Safety and toxicity profiles are still under investigation, and it is important to approach its use with caution, particularly in research settings. Overall, ANA 773 represents a significant interest in the field of cannabinoid research, particularly for its potential medicinal properties.

ANA 773

1174920-78-5: ANA 773, with the CAS number 1174920-78-5, is a synthetic compound that belongs to the class of cannabinoids. It is known for its selective agonistic activity at the cannabinoid receptors, particularly the CB1 receptor, which is primarily associated with the psychoactive effects of cannabinoids. The compound has been studied for its potential therapeutic applications, including its effects on appetite stimulation and pain relief. ANA 773 is characterized by its ability to cross the blood-brain barrier, leading to central nervous system effects. Its chemical structure includes a bicyclic framework, which contributes to its receptor binding affinity. As with many synthetic cannabinoids, the pharmacological profile of ANA 773 may vary based on dosage and individual biological factors. Safety and toxicity profiles are still under investigation, and it is important to approach its use with caution, particularly in research settings. Overall, ANA 773 represents a significant interest in the field of cannabinoid research, particularly for its potential medicinal properties.

<p>ANA773, an oral prodrug, activates TLR7 to stimulate immune cells and cytokine release, enhancing innate immunity.</p>

CAS 1174920-78-5

ANA 773

ANA-773

Ref: TM-T71325